Article Types

Pharmadesc Spectrum accepts a range of manuscript formats designed to capture the full spectrum of pharmaceutical and health sciences research — from traditional original research to newer formats addressing gaps we believe deserve more attention in scientific publishing.

Full-length reports of original research presenting new data, methods, or findings, following standard IMRaD structure (Introduction, Methods, Results, and Discussion).

Comprehensive, critical syntheses of existing literature on a defined topic, offering original interpretation and identifying gaps for future research — not a summary of existing summaries.

Concise reports of preliminary or focused findings that merit rapid dissemination ahead of a full research article.

Manuscripts developed with the assistance of AI tools for tasks such as literature organization, language editing, or analysis support, with full disclosure of AI use and complete human verification of all content. See our AI Use Policy for disclosure requirements.

Papers examining how AI tools and methods are applied within pharmaceutical and biomedical research itself — for example, evaluating large language models for literature synthesis or validating AI-assisted data analysis pipelines.

Well-designed studies that did not find a statistically significant effect. We believe these findings carry real scientific value and are underrepresented in pharmaceutical literature — Pharmadesc Spectrum actively welcomes them.

Shorter, opinion-informed pieces offering expert viewpoints on emerging trends, policy developments, or debates within pharmaceutical and health sciences.

Study protocols reviewed and accepted before data collection, with publication guaranteed based on the quality of the research question and methodology rather than the outcome.

Detailed, citable descriptions of study methodology published ahead of full results — particularly useful for multi-site or long-duration research.